Piper Jaffray Upgrades Alnylam Pharmaceuticals (ALNY) to Overweight
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $228.61 --0%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Join SI Premium – FREE
Piper Jaffray upgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) from Neutral to Overweight, price target increased from $10 to $12.
For more ratings news on Alnylam Pharmaceuticals click here and for the rating history of Alnylam Pharmaceuticals click here.
Shares of Alnylam Pharmaceuticals closed at $7.34 yesterday.
For more ratings news on Alnylam Pharmaceuticals click here and for the rating history of Alnylam Pharmaceuticals click here.
Shares of Alnylam Pharmaceuticals closed at $7.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Starts Alnylam Pharmaceuticals (ALNY) at Outperform
- Morgan Stanley Upgrades TWFG Insurance (TWFG) to Overweight
- Citi Upgrades Toyoda Gosei Co Ltd (7282:JP) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
